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Abstract 
 Chronic Obstructive Pulmonary Disease (COPD) is a chronic, progressive illness 
frequently encountered by primary care clinicians.  The Global Initiative for Chronic Lung 
Disease (GOLD) strategy offers the most robust evidence-based recommendations about the 
diagnosis and management of COPD.  Understanding and utility of GOLD in primary care is 
limited.  Goals of the project, to improve the quality of care for COPD patients, were based on 
Triple Aim Initiatives, COPD National Action Plan, and Healthy People 2020.  The quality 
improvement project implemented a one-time staff and provider education about GOLD strategy 
in caring for COPD patients in a primary care setting.  The quality improvement project also 
implemented a revised in-house spirometry testing workflow which incorporated GOLD strategy 
recommendations.  Data outcomes were derived from chart audits and EHR metric reports for 
120 COPD patients at a primary care clinic.  Outcomes from the four-month project showed 
increased rates of GOLD strategy recommendations.  There was an increase in the rates of 
spirometry confirmed diagnosis, increased rates of tobacco cessation counseling, increased rates 
of COPD Assessment Test performance,  increased rates of tobacco cessation by COPD patients, 
and decreased rates of prescriptions for inhaled corticosteroids.  The workflow was adopted into 
clinical practice at the site after completion of the implementation project.  
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Chapter One:  Overview of Chronic Obstructive Pulmonary Disease 
 Chronic Obstructive Pulmonary Disease (COPD) affects 16 million people in the United 
States (NIH, 2017).  COPD is an incurable, progressive, yet preventable chronic illness of 
reduced lung function, with millions of people still undiagnosed (NIH, 2017).  The National 
Institutes of Health released the COPD National Action Plan in 2015 to unify advancements in 
treatment and policy for COPD.  The Action Plan identifies key goals for diagnosing and 
managing this devastating disease.  Goal 2 of the Action Plan provided foundational principles 
for the project. “Improve the diagnosis, prevention, treatment, and management of COPD by 
improving the quality of care delivered across the healthcare continuum” (NIH, 2017, p.11). 
Applying the internationally recognized, evidence-based recommendations from the 
Global Initiative for Obstructive Lung Disease (GOLD) strategy into primary care practice was 
the aim of this project.  Primary care clinicians are in a unique position to translate goals into 
clinical practice.  This chapter will explore the background of COPD and current clinical practice 
standards from GOLD strategy for the diagnosis, treatment, and management of this disease. A 
brief overview of the quality improvement project that adapted GOLD strategy into a rural 
primary care practice will also be explored.    
Background of COPD 
 COPD is a progressive disease of airway obstruction, now the 4th leading cause of death 
in the US (CDC, 2018).  Features of both emphysema (hyperinflation of distal airspaces) and 
chronic bronchitis (persistent overproduction of mucus and cough) are present in COPD 
(McPhee, Papadakis & Rabow, 2018).   COPD patients usually present between ages 40 and 60 
with symptoms of breathlessness, cough, and/or copious phlegm (mucus).   
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GOLD strategy is a collaborative effort of multiple professional organizations guiding 
international standards for the diagnosis, management, and prevention of COPD.  GOLD defines 
COPD as a disease “characterized by persistent respiratory symptoms and airflow limitation that 
is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious 
particles or gases” (GOLD, 2019, p.1).   COPD is irreversible, and the prognosis is poor once 
significant airway limitation has occurred.  Treatment aims to relieve symptoms, minimize 
exacerbations, and reduce complications and mortality (Cash & Glass, 2017).  Early detection 
allows for earlier treatment.   
 Risks. Primary tobacco use, predominantly cigarette smoking, is the single most 
important modifiable risk factor in the development of COPD in the developed world.  Over 80% 
of COPD patients report a history of tobacco use (NIH, 2017).  Smoking is only one factor, and 
research is ongoing to better understand other risks, particularly in developing nations.  The most 
recent update of GOLD (2019) noted the inclusion of several additional risk factors in the 
development of COPD: indoor air pollution, occupational exposures, genetic factors, age and 
sex, lung growth and development, socioeconomic status, asthma and airway hyper-reactivity, 
chronic bronchitis, and a history of respiratory infections.   
Statistics.  According to the CDC’s 2014-2015 Behavioral Risk Factor Surveillance 
System, COPD has an age-adjusted national prevalence of 5.9%, while North Carolina (NC) 
prevalence is 7% (Sullivan et al., 2018).  Prevalence in southeastern NC is estimated between 7.1 
and 10% (Zhang et al., 2014).  Death rates in the US from COPD in 2014 were 39.1 per 100,000 
persons, a small decline from 43.3 calculated in 2008 (CDC, 2018).  Deaths from COPD 
decreased for men in the period 1999 to 2014, while rates for women did not (CDC, 2018).      
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Social determinants of health.  Lower socioeconomic status, whether defined by 
income or education, increases COPD prevalence by three-fold throughout the world (Pleasants, 
Riley, & Mannino, 2016).  An increased prevalence of COPD has been reported in US and NC 
households with income less than $25,000 a year, persons identifying as unable to work, those 
without a high school diploma, divorced/separated/widowed, and current/former smokers (CDC, 
2012).   Compounding this problem is the well-established connection between tobacco use and 
low socioeconomic status (Wang et al., 2018).   The National Advisory Committee on Rural 
Health and Human Services recently published a policy brief identifying barriers to care for 
COPD patients in rural, isolated communities, including a lack of specialist care (2019).  
Comorbidities and symptom burden.  The disabling nature of COPD symptoms is 
profound for the patients experiencing them.  “A population literally struggling for breath is, in 
consequence, unproductive” (Quaderi & Hurst, 2018, p.1).  Specialized components of the 
Behavioral Risk Factor Surveillance Survey (BRFSS) 2011 data include behaviors and quality of 
life questions for those living with COPD.  Nationally, 17.6% of respondents reported a hospital 
or ED visit for COPD symptoms within the previous 12 months (CDC, 2012).  NC data 
demonstrated a similar rate of 17.7%.  Of national respondents, approximately 64% reported a 
significant effect of breathlessness on their daily life; NC respondents experienced this 4% more 
(CDC, 2012).  These findings give context to the frequent finding of anxiety and depression in 
COPD patients.  COPD progression also results in weight loss, malnutrition, muscle atrophy, and 
anorexia.  Other frequently found comorbid conditions include lung cancer, cardiovascular 
disease, hypertension, peripheral vascular disease, and osteoporosis (GOLD, 2019).   
Exacerbations.  Exacerbations are defined as an acute increase in respiratory symptoms 
that result in additional therapy beyond normal daily variance (GOLD, 2019).  Exacerbations 
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vary in severity but lead to frequent provider visits, increased hospital utilization, secondary 
respiratory infections, and suboptimal medication use. Strategies aimed at reducing burden and 
cost should focus on reducing exacerbations, slowing the decline of pulmonary function, and 
reducing adverse symptoms (Ford et al., 2015).   
Significance of the Clinical Problem 
General goals of treatment for COPD are improvements in quality of life and reducing 
the frequency of exacerbations (Cash & Glass, 2017).  GOLD strategy provides an evidenced-
based step-wise approach to the diagnosis, assessment, and treatment of COPD.  
Spirometry testing is the diagnostic standard to evaluate airflow obstruction and establish 
the diagnosis of COPD.  Stages of disease progression are based on spirometry results: the ratio 
between predicted and actual forced expiratory volume (GOLD, 2019).  Recently GOLD strategy 
has placed increasing emphasis on evaluating respiratory symptoms to guide treatment, rather 
than staging alone (GOLD, 2019).  Updated recommendations included a standardized treatment 
process, known as the refined ABCD assessment tool (Appendix A).  
The ABCD assessment tool identifies exacerbation history (along the y-axis) and 
reported symptoms (along the x-axis).  The categories defined by boxes A, B, C, and D, are then 
used to identify appropriate pharmacological treatment.  There are two questionnaires 
recommended by GOLD to evaluate symptoms.  In years past, the Modified British Medical 
Research Council (mMRC) questionnaire, which focused exclusively on dyspnea, was most 
often used.  With the 2017 update, GOLD endorsed the COPD Assessment Test (CAT), which 
identifies symptoms beyond breathlessness alone (Appendix B).  
There are several algorithms derived from GOLD strategy for practitioners to utilize, 
which combine symptom assessments with spirometry values in guiding pharmacological 
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treatment.  The COPD Foundation offers the “COPD pocket consultant” a practical clinical tool  
which was utilized for the project (Appendix C; Yawn et al., 2017).  Other important 
considerations in COPD management include smoking cessation interventions, regular 
assessment of inhaler technique, and pneumococcal and influenza vaccinations.   
COPD Care in the Local Clinic  
 COPD is a complex illness largely overlooked until recent years.  Recommendations for 
treatment have not been fully adopted and utilized in the primary care setting.  Primary care 
providers are frequently the first to identify and treat COPD, and early intervention can move 
care towards Action Plan goals.  
 In a free, rural primary care clinic for low-income, uninsured adults in North Carolina, 
two components of GOLD strategy were routinely utilized.  First, staff performed in-house 
spirometry to diagnose COPD.  Second, providers counseled patients on tobacco cessation 
during routine visits. Both spirometry diagnosis and tobacco cessation data are tracked with 
quarterly chart audits.  The clinic’s goal was to incorporate more standards of care to improve 
symptom management and disease progression for COPD patients.  The project proposed to 
improve clinic uptake of GOLD strategy in accordance with COPD National Action Plan Goals 
2: improving diagnosis and treatment.   
Question Guiding Inquiry 
 Population. Primary care providers and nursing staff at the clinic were the population.  
Patients with suspected or diagnosed COPD would benefit from the improved diagnosis and 
treatment as recommended in GOLD strategy. 
Intervention.  First, education was provided to the clinic staff about GOLD strategy in 
primary care.  Education included spirometry performance and interpretation, CAT symptom 
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questionnaire use, tobacco cessation, inhaler education, and medication recommendations.   
Second, a revised workflow for spirometry visits was created for providers and staff.  Changes 
were made directly into the clinic's electronic health record (EHR).  
Comparison.  This intervention was compared to current care for COPD patients at the 
clinic: spirometry testing and tobacco cessation counseling.  Chart audit data in June 2019 of 
patients diagnosed with COPD revealed a 96% rate of smoking cessation interventions and a 
58% of spirometry confirmed diagnosis.  The clinic desired to improve both measures though no 
specific rate was defined.   
Outcomes. The outcome of the project was measurable improvements in selected 
components of GOLD strategy including spirometry rates, tobacco cessation counseling 
documentation, tobacco cessation rates, CAT symptom questionnaire, inhaled corticosteroid 
prescription rates, and healthcare utilization in the form of ED/hospitalizations.  These measures 
were evaluated with EHR generated reports and chart audits.  Outcomes were congruent with the 
COPD National COPD Action Plan goals and the Triple Aim Initiative.   
Summary 
COPD is a debilitating disease marked by a progressive loss of lung function over time.  
COPD disproportionately affects people in rural locations and those with lower socioeconomic 
status.  Initiatives to improve COPD care include the COPD National Action Plan and Healthy 
People 2020 goals.  Goals for COPD treatment are intended to manage symptoms, decrease risks 
of exacerbations, and improve mortality from this illness. GOLD strategy is an internationally 
recognized, evidence-based set of recommendations that can be adapted at the primary care level 
to diagnosis and treat COPD.   
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The project site was engaged in pursuing measures to improve care for suspected and 
diagnosed COPD patients. The project aimed to improve the diagnosis and management of 
COPD by educating staff on GOLD strategy and providing a revised workflow for spirometry 
visits.  The intent of this project was to improve the lives of patients with a quality improvement 
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Chapter Two:  Review of the Literature  
GOLD strategy is the international standard for the diagnosis and management of COPD.   
The adaptation of this strategy into clinical practice has varied worldwide.  Reasons include 
knowledge gaps and accessibility of recommendations, geographic location, prevalence, the 
complexity of healthcare systems, ongoing research, and availability of treatment options.  
Ongoing advancements in understanding and treatment of COPD have complicated the ability to 
adopt standards of care to the primary care level.   
This chapter will examine the ways in which GOLD strategy has been implemented in 
the literature.  Recent and ongoing research about specific aspects of the GOLD strategy, the 
utility of standardized questionnaires, and pharmacological management will be examined for 
use in clinical practice.  Data regarding implementation strategies for GOLD strategy in primary 
care and further literature strategies will be reviewed.  Applicability of the literature review to 
the proposed project will be discussed. 
Literature Appraisal Methodology  
Sampling strategies.  Search terms for literature review included the following: 
“outpatient”, “out-patient”, “primary care”, “global initiative for chronic obstructive lung 
disease”, “GOLD”, “GOLD guidelines”, “COPD”, “chronic obstructive pulmonary disease”, 
“global strategy for the diagnosis, management, and prevention of COPD”.  PubMed, Scopus, 
and OneSearch were used.  Results were limited to literature published within the past 5 years, 
peer-reviewed, and written in English.  One exception to the time limitation was made: the 2007  
study by Foster, Yawn, Maziar, Jenkins, Rennard, & Casebeer, which was the first and only 
formal evaluation of GOLD strategy applied to clinical practice.  Further limitations included 
those containing abstract details for outpatient COPD management, GOLD recommendations 
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adherence, implementation of GOLD recommendations, specific instruments of GOLD 
recommendations including COPD Assessment Test (CAT), and the Modified British Medical 
Research Council (mMRC) questionnaires.  The total number of articles retrieved with these 
parameters was 724; total articles reviewed with abstract data were 86; articles selected for 
critical review were 53 (Appendix D). 
Ongoing search strategies included manual reviews using revised search terminology 
adapted to the needs of the project.  Close attention was paid to the International Journal of 
COPD, whose literature was the most robust and current.   
Evaluation criteria.  Inclusion criteria included the following: literature reviews, 
systematic reviews of randomized controlled trials, meta-analysis, guidelines, guideline 
summaries, reviews of guidelines, expert opinions, cohort/observational studies, case study, and 
survey studies. All levels of evidence were considered, and I, II, IV, V, and VI levels of evidence 
were utilized in the review.  
Exclusion criteria included findings related to drug trials for COPD medications, oxygen 
supplementation, surgical interventions, pulmonary rehabilitation studies, examinations of co-
morbidities, asthma and asthma/COPD overlap, and studies and reviews of COPD interventions 
in settings other than outpatient or primary care.  A literature matrix provides a summary review 
of all included sources (Appendix E).  
Literature Review Findings 
The 2019 GOLD Global Strategy for Prevention, Diagnosis, and Management of COPD 
is the most recent update to the international standards of care for COPD.  National 
organizations, including the American Thoracic Society, American College of Chest Physicians, 
and American College of Physicians, use GOLD strategy to produce clinical practice guidelines.  
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Many components of GOLD strategy are common throughout the literature: use of post-
bronchodilator (BD) spirometry values for diagnosis, medication adherence that includes a long-
acting BD with the presence of significant symptoms, pneumococcal vaccinations, smoking 
cessation counseling, and inhaler technique education. GOLD (2019) offers the ABCD 
assessment tool as an algorithm for medication guidance to initiate and titrate treatment based on 
symptoms (Appendix B).  The COPD Foundation offers the “COPD pocket consultant” intended 
for both primary care and hospital bedside providers (Appendix C).  Adherence and 
implementation of GOLD strategy vary in the literature.   
Implementation initiatives in primary care practice.  Research trials and data 
regarding implementation strategies applying GOLD strategy to primary care settings are rare. 
Integrated disease management (IDM) is a model that has been used to implement COPD 
recommendations into clinical practice.  A Cochrane review by Kruis et al. (2013) evaluated 26 
randomized control trials of IDM involving approximately 2000 patients.  While the definition of 
IDM was broad, important GOLD strategies such as smoking cessation, medication adherence, 
and self- management/patient education strategies were included.  Self-reported quality of life, 
exercise tolerance, reduced hospital admissions, and length of stay were notable findings (Kruis 
et al., 2013). 
Clinical decision support systems (CCDSS) have also been used in practice to implement 
recommendations in primary care.  CCDSS interventions are computerized point-of-care 
reminders embedded within the electronic workflow, such as forms, templates, alerts, reminders, 
and order sets, giving suggestions about clinical care (Fathima, Peiris, Naik-Panvelkar, Saini, & 
Armour, 2014).  The authors reviewed 16 randomized control trials of CCDSS for asthma and 
COPD care in primary care, representing an array of interventions (Fathima et al., 2014).  
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Overall, 75% of the studies demonstrated statistically significant improvements in clinical 
outcomes for patients and process quality measures in practice (Fathima et al., 2014).   
Adherence to GOLD strategy  in primary care.  Studies evaluating general adherence 
to GOLD strategy in primary care are limited and demonstrate the gap in clinical application.  
Historical data from Foster et al. (2007) notes that bridging the gap between evidence and 
practice has been a challenge from the first GOLD document.  The study, sponsored by the 
COPD Foundation, surveyed more than 700 primary care physicians.  Over 60% of physicians 
considered their COPD education inadequate, and 45% were unaware of clinical practice 
recommendations (Foster et al., 2007).   
A recent examination of the literature shows a similar picture, with a wide range of 
GOLD strategy adopted into clinical practice.  Sehl, O’Doherty, O’Connor, O’Sullivan, & 
O’Regan (2018) reviewed 11 quantitative studies describing varying use of spirometry, 
awareness of recommendations, medication management, vaccination status, documentation of 
smoking cessation counseling, and inhaler teaching.  Two common barriers to practice emerged 
in this review: time constraints and lack of familiarity with guidelines.  This information was an 
important consideration in developing the education portion of the project.   
GOLD strategy and clinical practice guidelines underscore post-bronchodilator 
spirometry as the primary diagnostic tool for COPD.  Yet, the application of this 
recommendation is inconsistent.  In one retrospective chart analysis in the US, only 27% of 1500 
COPD patients had documentation of spirometry (Belletti, Lui, Zacker & Wogen, 2013). 
Barrencheguren et al. (2015) examined a database of 40,000 newly diagnosed patients with 
COPD with similar results: nearly half had no spirometry data in the health record.   
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The “Continuing to Confront COPD International Physician Survey” sought to examine 
the application of COPD practice recommendations by comparing respiratory specialist 
physicians to primary care physicians (Davis et al., 2015).  Case-study response surveys showed 
that 82% of primary care physicians routinely used spirometry for diagnosis, compared to 100% 
of respiratory specialists (Davis et al., 2015).  Overall knowledge varied considerably, with 85% 
of primary care providers noting awareness of any COPD guideline, compared to only 58% 
awareness of GOLD strategy specifically (Davis et al., 2015).  Of those acknowledging GOLD 
strategy, 59% described an actual change to their practice (Davis et al., 2015).    
Some practices are successfully translating knowledge into practice.  A randomized trial 
of 700 Chinese patients with COPD evaluated patient outcomes between an intervention group 
(provider education on GOLD strategy) and a control group (usual care).  The study showed a 
statistically significant difference in 6-minute walk distance, self-reported symptoms via mMRC 
questionnaire, and quality of life measures for the intervention group patients (Jiang et al., 2015).  
The provider education included four training sessions with topics covering smoking cessation, 
spirometry confirmed diagnosis, and medication recommendations (Jiang et al., 2015). Their 
results demonstrate that provider education directly impacts patient outcomes.  
Symptom assessment tools.  Beginning in 2011, GOLD strategy was updated to include 
assessment of symptoms in addition to spirometry for the management of COPD (GOLD, 2019).  
The CAT and mMRC questionnaires have been incorporated in the ABCD assessment tool.  
Severity increases with the assessment tools’ letters: A (low risk, fewer symptoms), B (low risk, 
more symptoms), C (high risk, fewer symptoms), D (high risk more symptoms).  Clinicians are 
faced with a challenge; however, when determining which questionnaire to use.   
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The GOLD 2019 strategy recommends the CAT specifically, noting that dyspnea is not 
the only measurement of symptom burden in COPD (GOLD, 2019).  Data regarding the utility of 
these tools is ongoing.  Gupta, Pinto, Morogan, & Bourbeau (2014) measured psychometric 
properties of the CAT, deeming it internally consistent, responsive to actual healthcare 
utilization, and reproducible over time.  In a separate systematic review and meta-analysis, the 
CAT was demonstrated to have significant predictive abilities; impressively, the CAT predicted 
COPD exacerbations, worsening of health status, depression, and mortality (Karloh, Mayer, 
Maurici, Pizzichini, Jones, & Pizzichini, 2016).   
Evidence does reveal flaws in the scoring of the CAT and mMRC.  One recent study 
concluded that the ABCD classification of COPD patients was significantly different, depending 
upon which of these questionnaires were used (Karloh et al., 2016).  Multiple examinations of 
existing data suggest that cutoff points for the questionnaires described in the ABCD assessment 
tool are not equivalent and need more research (Karloh et al., 2016; Mapel, Dalal, Johnson, 
Becker, & Hunter, 2015).   
Use of bronchodilators.  As with the general uptake of GOLD strategy, there is varying 
adherence in use of recommended inhaled medications for COPD in primary care.  Recent 
literature describes frequent BD prescriptions without spirometry confirmed diagnosis (Sehl et 
al., 2017; Overington et al., 2014).   GOLD strategy recommends that COPD severity should be 
staged with spirometry and symptoms assessed prior to prescribing medications (2019).   
Historical data from Foster et al. (2007) demonstrates prescriptive practices incongruent 
with GOLD strategy.  In physician self-reported practices, only 36% of primary care physicians 
used recommended long-acting BD medications for specific categories of COPD. Responses in 
the “Continuing to Confront COPD International Physician Survey” indicated that neither 
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primary care providers nor respiratory specialists were particularly adherent to recommendations 
for inhaled medications (Davis et al., 2015).  In one example, both types of providers were only 
60% concordant with recommended bronchodilator medications (Davis et al., 2015).   
Inhaled corticosteroids (ICS) have been another mainstay of treatment, most recently 
supported in drug trials for use in severe COPD and frequent exacerbations (Riley & Sciurba, 
2019).  However, ICS may be overused, providing minimal benefits and notable risks of use 
including an increased incidence of bacterial pneumonia and oral thrush (Riley & Sciurba, 2019).  
Sehl et al. (2017) found 30% of physicians utilizing ICS as an initial medication regardless of 
stage.  Similarly, Davis et al. (2015) noted the use of ICS as initial treatment for mild stages of 
COPD.   Overuse of combined triple therapy (both types of long-acting bronchodilators together 
with ICS) is consistently noted in the literature (Overington et al., 2014; Sehl et al., 2017; Davis 
et al., 2015).  In one observational study involving claims-based data, 75% of COPD patients 
with documented triple therapy did not have the appropriate GOLD category of disease to justify 
use per GOLD strategy (Simeone et al., 2017).  
Costs of COPD care and management.  The chronic nature of COPD and increased 
medical interventions during disease progression create burden of cost to the healthcare system 
and patients.  A recent review of the literature by ur-Rehman (2019) showed the average length 
of stay in the US for COPD exacerbation was 4.8 days.  Depending on disease severity, this can 
be two to three times a year (GOLD, 2019).  Hospitalizations are an enormous cost of care per 
patient with COPD, estimated at $6,852 annually.  Emergency Department costs alone were 
$2380 annually (ur Rehman et al., 2019).  This is directly influenced by disease severity and 
exacerbation frequency.  Early and frequent interventions that utilize best practice are important 
in reducing the overall cost of care for COPD patients (ur Rehman et al., 2019).  Reducing the 
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overall cost of care is an essential focus of the Triple Aim Initiatives recommended by the 
Institutes for Healthcare Improvement.  
Limitations of Literature Review Process  
Adherence and implementation practices in the primary care setting  have not been well 
researched. “There are very few studies assessing the effect of COPD guideline implementation 
on patient outcomes, and this is an area that requires further research” (Overington et al., 2014, 
p.1593).  In addition, no studies were found pertaining to rural primary care management of 
COPD.  Also, there was no clear evidence of the role of the nurse practitioner in the care of 
patients with COPD.  Most studies have been conducted in the medical specialty fields of 
pulmonology and pharmacology.  
Discussion  
Conclusion of findings.  There are limited data describing implementation strategies for 
GOLD strategy in primary care.  There has been wide variation in the clinical application of 
GOLD, frequently cited in studies utilizing chart reviews and provider surveys.  Major gaps in 
the application of GOLD strategy include spirometry diagnosis, knowledge of recommendations, 
and prescriptive practices.  Frequently identified barriers in adherence to using GOLD 
recommendations include time constraints, lack of familiarity with recommendations, and 
complexity of recommendations (Overington et al., 2014; Sehl et al., 2018).  The most recent 
version of GOLD 2019 “pocket guide” is 44 pages in length.   
A review of the literature demonstrates a need for provider and staff education on GOLD 
recommendations. It is important that education on GOLD strategy emphasizes spirometry-based 
diagnosis and understandable algorithms for treatment recommendations. Methods used to 
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evaluate the implementation of GOLD strategy would be best measured by chart audits, which 
have been proven to be useful in past studies evaluating adherence.   
Advantages and disadvantages of findings.  Providing education to providers about 
GOLD strategy is a demonstrated need in the literature. Increasing awareness of GOLD strategy 
in clinical practice has the potential to improve the quality of life, disease progression, and 
healthcare costs for care of COPD patients.  These goals are congruent with the 2015 COPD 
National Action Plan for translating recommendations into practice.  In addition, Healthy People 
2020 goals include measures for reducing hospitalization, mortality, and improving quality of 
life for COPD patients.   
Disadvantages include the lack of implementation strategies in the literature for education 
in primary care.  There is limited information about which education tools work best for COPD 
specifically.  Further research is also needed to identify the best methods of dissemination of 
information in primary care settings.  Other disadvantages included conflicting information about 
symptom questionnaires and whether the CAT and mMRC should be considered interchangeable 
when using treatment algorithms.   
Utilization of findings in practice change.  Project implementation plans focused on  
teaching and consideration of time constraints for providers and staff.  Education plans were 
designed to succinctly address GOLD strategy for the assessment, diagnosis, treatment, and 
management of COPD at the primary care level.   
Recommendations made by Overington et al. (2014), based on a review of methods used 
for other chronic diseases, were applicable to the project design.  The accessibility of 
recommendations at point-of-care locations, providing an active/live education opportunity, and 
incorporating reminders within the EHR were strategies notable to the project (Overington et al., 
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2014).  Adjustments were made directly in the clinic EHR for ease of access and improved 
workflow. 
Summary 
This chapter has identified the need for improved education about GOLD strategy in 
primary care.  Clinical application of GOLD strategy varies throughout the literature, with lack 
of knowledge and time constraints identified as primary barriers to care.  The project's intent was  
to bring education and actionable strategies based on GOLD to the project site.  These goals 
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Chapter Three:  Theory and Concept Model for Evidence-based Practice 
Theoretical and conceptual frameworks are integral to develop, implement, and evaluate 
the project.  This chapter will describe important concepts of the project, the theoretical basis of 
the project, and the conceptual model selected to guide implementation.  Concepts explored will 
include COPD, GOLD, exacerbations, symptom burden, and project outcome. The Diffusion of 
Innovations Theory (DOIT) was the overall theoretical basis for the project, guiding the 
development of education and workflow strategies, and identifying appropriate communication 
channels for dissemination.   The Plan-Do-Study-Act (PDSA) conceptual model guided the 
implementation and evaluation of the interventions.  Current examples of theory and conceptual 
model used in the literature will be identified.   
Concept Analysis 
 Major concepts of the project include COPD, GOLD recommendations, exacerbations, 
and symptom burden.  The outcome concept is the improvement in the spirometry visit workflow 
conducted at the clinic.   Outcomes were measurable patient outcomes derived from EHR queries 
and chart audits.   
 COPD.  COPD is a progressive disease of airway obstruction, exhibited by 
hyperinflation of distal airspaces and the persistent overproduction of mucus and cough 
(McPhee, Papadakis & Rabow, 2018).   Because COPD is a progressive, chronic, and 
irreversible disease of airway destruction, treatment goals aim to relieve symptoms, minimize 
exacerbations, and reduce complications and mortality (Cash & Glass, 2017).  Spirometry is the 
diagnostic test used to confirm COPD definitively.  Comparing rates of forced expiratory 
volume, or the amount of air in a forced exhalation, using a bronchodilator medication is the 
diagnostic standard (GOLD, 2019).  
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GOLD.  The Global Initiative for Chronic Obstructive Lung Disease (GOLD) is a 
collaborative effort of professional organizations guiding international standards for the 
diagnosis, management, and prevention of COPD.  GOLD was originally developed as a think 
tank, later creating a scientific committee that produces evidence-based recommendations for the 
management of COPD (GOLD, 2019).  The formal GOLD Strategy document is revised every 
five years.  Science committee members have clinical and academic expertise, and disclosures of 
interest are updated yearly. Levels of evidence are ranked with each subsequent report, with 
grades A to D assigned to each recommendation in published reports (GOLD, 2019). GOLD 
defines its objectives to recommend management strategies, increase public awareness of the 
disease, implement and evaluate effective programs for diagnosis and treatment, and promote 
COPD research (GOLD, 2019).  
 Exacerbations.  Exacerbations are acute increases in symptoms of COPD, causing a 
change in treatment, such an outpatient adjustment in medication or intensive interventions 
within a hospital setting.  Exacerbations, often triggered by respiratory infections or 
environmental irritants, are a combination of increased hyperinflation, gas trapping, and 
inflammation, with reduced expiratory flow, resulting in significantly increased dyspnea (GOLD, 
2019).  The goals of COPD management are focused on reducing the frequency and severity of 
exacerbations (Cash & Glass, 2017). 
Symptom burden.  Symptom burden is the fluctuating pattern of dyspnea, cough, 
wheezing, chest tightness, and sputum production in the COPD patient that negatively affects 
quality of life (GOLD, 2019).  All aspects of life are affected by symptom burden, including 
employment, physical activity, activities of daily living, nutritional status, sleep patterns, family 
functioning, self-perception, and mood.  Symptom burden changes through the course of illness 
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are relative to exacerbation periods and are directly linked to increased utilization of healthcare 
resources (Ding, Small, & Holmgren, 2017).  Increasing frequency and severity of exacerbations 
are indicative of progressing disease severity, loss of lung function, and worsening of COPD.  
 Project Outcome.  A revised spirometry visit workflow is the project outcome.  This will 
be evidenced by measurable data concerning rates of spirometry performed, documentation of 
the CAT symptom questionnaire, tobacco cessation counseling, rates of tobacco cessation, 
inhaled corticosteroid use, and healthcare utilization.  
Theoretical Framework  
Naming the theory.  The Diffusion of Innovation Theory (DOIT) developed by Everett 
Rogers is the conceptual theory for this project.  DOIT provides a framework with which to 
understand how innovations are spread and utilized (Rogers, 2003).  While DOIT was first 
identified in the context of agricultural innovations, it has been adopted in a variety of 
disciplines, including public health, medicine, nursing, social work, and behavioral health 
(Hayden, 2017).  DOIT is versatile in research, quality improvement, and implementation 
strategies.   
The Diffusion of Innovation Theory (DOIT) is a model that explains how and why new 
ideas are spread.  DOIT varies by the culture where an idea is being spread, the characteristics of 
the adopters, and the innovation-decision process (Hayden, 2017).  DOIT  contains four main 
constructs: the innovation (or idea), channels through which the idea is communicated, time, and 
the social system through which this occurs.  Each of these components has important aspects 
relative to the uptake of an idea.   
Characteristics of innovation are defined as relative advantage, trialability, complexity, 
and compatibility. Communication channels are defined as the vehicle through which people 
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obtain information about innovation, primarily through mass media and interpersonal means 
(Rogers, 2003).  The social system can be several individuals, groups, or organizations “engaged 
in solving a joint problem to accomplish a goal” (Hayden, 2017, p.483).  Individuals within the 
social system are referred to as adopters. Adopter categories are defined by how rapidly or 
slowly, they adopt an innovation over time.  Time is defined as the rate at which information is 
shared, and innovations are adopted. From quick to slow rates, adopters are defined in the 
following categories: innovators, early adopters, early majority, late majority, and laggards 
(Rogers, 2003).   The overall process of accepting an innovation has five stages: knowledge, 
persuasion, decision, implementation, and confirmation.  A schematic model of these elements of 
the DOIT can be seen in Appendix F.      
Examples of DOIT in the literature.  Many aspects of DOIT have been utilized in 
healthcare quality improvement.  Care plans, care management strategies, and care bundles have 
recently been explored on a broad scale using DOIT as a theoretical model for systematic 
reviews.  Dementia care plans in the outpatient setting were examined to understand varying 
rates of success.  DOIT constructs of attributes of innovation, communication channels, and 
characteristics of adopters were reviewed across practice locations and implementation plans 
(Khanassov, Vedel, & Pluye, 2014).  Approached from this theoretical perspective, limitations, 
and facilitators of implementation were clearly identified, and strategies for improvement were 
developed.  Care management plans for other disease types have been reviewed in a similar 
manner.  Miake-Lye et al. (2017) systematically reviewed over 1400 responses to the National 
Survey of Physician Organizations Review survey. Using DOIT, their answers were analyzed by 
innovation characteristics, revealing that prior experience and simplicity were critical to the 
adoption of care plans, regardless of disease type (Miake-Lye et al., 2017).   
GOLD IMPLEMENTATION  29  
In another context, hospital discharge care bundles for COPD were evaluated as an 
innovation using DOIT.   Responses from 13 focus groups identified challenges in staffing, 
infrastructure, process, use of improvement methodology, and patient involvement (Lennox et 
al., 2014).  With staff as adopters, the authors identified the need to engage staff early and 
consistently, clearly identify roles of the team, and encourage personal ownership.  
 In research similar to the project, DOIT was used to evaluate a COPD screening program 
at an indigent clinic (Estes, Short, Bowser, & Boyle, 2014).  A novel COPD screening 
questionnaire was used to identify patients who were then assessed and treated with GOLD 
recommended measures.  Using DOIT in post-implementation evaluation, the intervention was 
determined to be too resource-intensive and unsustainable.     
 Application to practice change.  Two major constructs of DOIT guided the project: 
characteristics of innovations and communication channels.   Innovations of the project are 
defined as the education modules and revised spirometry workflow.   
Optimizing characteristics of the innovation (relative advantage, trialability, complexity, 
and compatibility) will guide the development of education modules and workflow.  Relative 
advantage of the innovation was illustrated by the project’s foundation in current GOLD 
strategy. The trialability of the innovation was demonstrated by piloting the education modules 
and workflow with staff during implementation. Trialability was enhanced by regular 
communication with staff and providing workforce support for spirometry visits during 
implementation.  Complexity was reduced by providing innovation that was sensitive to the time 
constraints of staff.  Complexity was reduced by integrating multiple components of the 
workflow directly into the EHR.  Eliciting feedback from the site champion and key stakeholders 
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during the development and implementation stages of the innovation further optimized each of 
these characteristics.   
Channels of communication that distribute information about the innovation are both 
interpersonal and electronic.  The innovation was disseminated electronically with clinic intranet 
and public internet.  Education modules were available at a live session and offered in electronic 
form to all other staff at the clinic.  Types of adopters, early, late, and laggards, were identified 
during communication about the innovation.  Interpersonal communication occurred individually 
with staff during all phases of the project, including the project leads’ weekly presence at the 
clinic.  Interpersonal communication strategies were more likely to improve the uptake by late 
adopters and laggards.  
Evidence-Based Practice Change Theory  
Naming the Change Model. The Plan-Do-Study-Act (PDSA) model has become a 
versatile change model in healthcare quality improvement.  Originally developed by Walter A. 
Shewhart in the 1920s, the Plan-Do-Check-Act cycle was further developed by W. Edwards 
Deming in Japan after WWII to improve production in the industry (Butts & Rich, 2018).  This 
model encourages a detailed looked at a process, with repeated cycles of improvement.  As the 
name implies, PDSA has four phases: plan, do, study, and act (Butts & Rich, 2018).  The Plan 
cycle defines a problem within a process and identifies potential solutions.  The Do cycle 
includes small-scale testing of the change identified in the planning cycle.  The Study (or Check) 
cycle evaluates and analyzes the results of the Do cycle.  The Act cycle can include either 
implementing the successful changes to formal practice or applying results to evolve the next 
Plan cycle.  
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PDSA in the literature.  A review of the literature shows a multitude of applications of 
the PDSA model in health care.  In one study, care for opiate-dependent neonates in a hospital 
was dramatically improved by utilizing 11 PDSA cycles over the course of three years (Holmes 
et al., 2016).   Overall hospital costs were reduced in the study, including length of stay for 
infants and pharmacological interventions.  Meanwhile, organization improvements occurred, 
including standardizing assessment tools, improving family education, and increasing family 
participation in care (Holmes et al., 2016).    
Stover and Harpin (2015) also used the PDSA model, through seven cycles in two years, 
for the psychiatric patients of an emergency department.  Using the PDSA model, wait times 
were reduced, enabling these patients to receive appropriate care quickly.  
Application of PDSA to practice change. There were great advantages to using the 
PDSA quality improvement process in the project.  During the project, PDSA provided a 
framework to quickly adapt feedback from staff, providers, and stakeholders during the 12-week 
implementation phase.   
PDSA cycles provided the project lead and staff the opportunity to give feedback about 
the revised spirometry workflow.  The rapid cycle PDSA model allowed the revised spirometry 
workflow to be implemented, assessed, altered and then implemented again with each cycle.  For 
formal PDSA cycles with clinic staff, the workflow was developed and implemented in the 
“Plan” phase.  Staff were observed by the project lead while performing the spirometry visits 
during the “Do” phase.   A feedback session occurred after these visits in the “Study” phase, and 
results reviewed with the project champion.  In the “Act” phase, adjustments were finalized and 
adopted into the workflow.  Ultimately the PDSA structure elucidated evaluation and 
recommendations for sustainability at the site.  
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Summary 
 This chapter has explored the most important concepts of the project and identified the 
outcome as a concept.  Theoretical frameworks and conceptual models of change have been 
identified to aid in the creation, revision, implementation, and evaluation of the project.  The 
Diffusion of Innovation Theory provides a theoretical framework for the creation and adaptation 
of education and revised workflow. The PDSA conceptual change model will provide a 
systematic way of revising the workflow with staff input.  The refinement of the project was 
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Chapter Four:  Pre-implementation Plan 
This chapter will describe the creation of the project and steps taken before 
implementation at the site.  The project intent and detailed development will be discussed.  A 
risk assessment will be detailed, and an overview of the approval process will be given.  Specific 
data collection and evaluation of the project will be described.   
Project Purpose 
The purpose of this quality improvement project was to increase staff and provider 
awareness of best practices for the diagnosis and management of COPD in an outpatient setting.  
The project was based on the 2019 Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) Strategy.  In line with GOLD strategy, the clinic was already performing spirometry 
testing visits for suspected and diagnosed COPD patients.  A goal of the project was to improve 
the current spirometry testing visit workflow within the electronic health record (EHR).  A 
checklist of actionable GOLD strategy-based items within the EHR was created for providers to 
utilize during patient visits.  The project site was a free primary care clinic serving low-income, 
uninsured adults in rural southeastern NC.     
The success of the project was evaluated by rates of the following for active COPD 
patients at the clinic: spirometry testing, tobacco cessation counseling, tobacco cessation, use of 
COPD symptom questionnaires, prescriptions for inhaled corticosteroids, and health care 
utilization (ED use and sick visits).   No personal health information was collected.  
Implementation of the improved spirometry workflow was to begin in September 2019.  Weekly 
spirometry visits were planned, and chart audits were to be conducted from August through 
December. The project’s goal, to improve the diagnosis, treatment, and management of COPD, 
was in line with Healthy People 2020 goals for COPD and the 2017 COPD National Action Plan.  
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Project Management 
Organizational readiness for change.  Site representatives showed interest in the 
project idea from the initial discussion.  The site champion and director had been considering 
strategies for grant funding and improved outcomes for COPD patients.  Readiness for change 
was demonstrated by enthusiasm, willingness to discuss development at regular intervals, and 
providing suggestions.  Site champion and site director supplied resources in the form of time, 
staff, and supplies to support the planning and implementation of the project.  
Interprofessional collaboration. The site champion, the only full-time provider at the 
clinic, played a vital role in the development and planning for project implementation.  The site 
champion assisted in the development of spirometry workflow and provided valuable insight into 
the needs of COPD patients and clinic staff.  The site director supported the implementation by 
offering expertise in the area of EHR workflow, creating and generating EHR reports for data 
collection, and supplying resources to perform spirometry in the clinic.  Nursing staff performing 
spirometry included one full-time staff and two volunteers who were to provide feedback about 
the workflow during PDSA process improvement.  The project lead took the lead role in 
communicating about the project to the site and facilitating discussion about the project.  The 
project lead communicated with each discipline, from provider to administrative staff, with 
information about the project relevant to their role, and it functions within the project intent. 
Risk management assessment. A risk assessment was performed by the project lead 
using a strengths, weaknesses, opportunities, and threats (SWOT) analysis.   Risk assessment is a 
valuable tool to identify the internal and external influences that surround a project or plan.  
Positive and negative implications of a project can be identified, described, and explored in this 
way prior to implementation.  
GOLD IMPLEMENTATION  35  
The strengths of the project included a direct benefit to COPD patients by increasing the 
efficiency of the encounter between patients and staff.  Sustainability and ease of use were 
potential strengths of the project since changes to the workflow and actionable items were built 
directly into the clinic’s EHR.   
The weaknesses of the project included the limitations of staff and resources.  The project 
site was a free clinic operating on a limited budget with few paid staff.   Teaching a new process 
and creating additional workload for staff and volunteers were identified as a weakness.     
Opportunities for the project included the acquisition of data for COPD patients to be 
used for potential grant funding.  The project allowed the clinic to enhance its alignment with the 
policy and practice recommendations of the National Institutes of Health, Rural Health Initiative, 
and Healthy People 2020 goals.  Other opportunities included a workflow strategy framework 
that could be used for other types of standardized testing performed at the clinic.   
Threats to the project included the complexity of the patient population.  Patients often 
have discordant care related to loss of insurance, leading to high rates of no-shows and 
cancellations.  Time was another threat to the project.  Changes in data trends are often limited in 
short project periods.  In addition, not all active COPD patients had a provider or spirometry visit 
during the implementation phase, making data collection skewed towards patients with newly 
diagnosed COPD.   
Organizational approval process.  The project was the result of an existing relationship 
between the project lead and the site.  The project lead had been a volunteer at the clinic for over 
a year prior to the project.  The site champion and director were approached in the fall of 2018 
with the project idea.  Two brainstorming sessions occurred following the initial conversation. 
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The site champion and director provided feedback about current and future goals for measures in 
the COPD population, particularly smoking cessation and healthcare utilization. 
Additional meetings occurred in the Spring of 2019; email and telephone conversations 
communicated changes to the project idea during that time.  Concerns about staff support, time, 
and resource limitations inherent to the free clinic were addressed at regular intervals.  With the 
project lead offering to perform spirometry testing, as had been done in a volunteer capacity, the 
site representatives were confident and supported the implementation phase of the project.  The 
site director provided an organizational support letter as final approval to conduct the project at 
the clinic  (Appendix G). 
Information technology. Information technology for use in the  project included 
AllScripts Professional™, the EHR management system used by the clinic.  The site director and 
project lead were able to edit templates within AllScripts Professional™, allowing an improved 
electronic workflow for clinic staff and providers. The site director and project lead created 
reports with AllScripts Professional™ generating reports for evaluation of outcome measures.  
No patient-specific demographics or protected health information was collected.  The following 
Microsoft© applications were used when creating education for the clinic and communicating 
with the clinic: Word, PowerPoint, Excel, and  Outlook Email.   
Cost Analysis of Materials Needed for Project 
 Costs related to the project were minimal.  Documents requiring paper copies were 
printed at the site.  Education materials, spirometry visit workflow directions, and symptom 
questionnaires were stored on the clinic server after printing.  The “COPD pocket consultant” 
guides were ordered in quantity enough for the clinic, requiring only a small shipping fee.  A 
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clinical staff meeting provided an opportunity for on-boarding and education on GOLD strategy.  
Appendix H contains an itemized budget for the project with an estimated cost of $82.50. 
Plans for Institutional Review Board Approval 
 The project site did not have an IRB or a formal approval process for the project.  
Approval occurred by meeting with the site champion and director to explain the intended 
purpose of the project and implementation plan.  A letter of approval from the site was drafted, 
reviewed, and completed (Appendix G). The project lead completed the University IRB 
verification process using the IRB QI/Program Evaluation Self-Certification Tool.  After 
obtaining approval from the faculty lead, the tool was submitted online.  The project was deemed 
quality improvement, and immediate response was received, stating that IRB review was not 
required (Appendix I).   
Plan for Project Evaluation  
Demographics. Participants in the project were providers and nurses at the clinic.  The  
clinic staff was composed of the director, nurse practitioner provider, registered nurse, and two 
certified medical assistants. Volunteers at the clinic included multiple registered nurses, 
physician assistants, nurse practitioners, and physicians with varying hours and patient 
interaction.   Two registered nurse volunteers and the staff registered nurse were performing 
spirometry visits.  Information about the project and education modules developed by the project 
lead was made available to all volunteers and staff.   
Primary outcomes for the project were evaluated by a monthly review of COPD patient’s 
charts and reports generated via AllScripts Professional™.  No personal health information was 
gathered, and no subjects were identified.  COPD patients included in data capture included 
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active patients, defined as having had a visit within the year 2019, that had a documented 
diagnosis of COPD in the EHR.    
Outcome measurement.  Monthly queries were created within AllScripts Professional™  
to trend and track GOLD strategy components for active patients with a COPD diagnosis at the 
clinic: the presence of spirometry results, tobacco use status, tobacco cessation counseling codes, 
CAT symptom questionnaire codes, and inhaled corticosteroid prescriptions.  Data were reported 
in monthly percentages and later displayed in graphs (Appendix J).  Data collected from chart 
audits examining healthcare utilization were similarly displayed (Appendix K).  
Outcome A. Rates of spirometry results documented in the EHR  were an outcome 
measure of the project.  Standard practice at the site was an annual EHR generated query of these 
rates.  A new query was developed to capture monthly rates of spirometry for suspected and 
diagnosed COPD patients.  Rates of spirometry results were evidence of GOLD strategy 
adherent clinical practice.  Post-bronchodilator spirometry is the definitive diagnostic tool for  
COPD (GOLD, 2019).       
Outcome B. Rates of tobacco cessation counseling documented in the EHR was an 
outcome measure of the project.  Monthly queries were generated to determine the number of 
COPD patients receiving tobacco cessation counseling during a visit to the clinic. Percentages 
and frequencies were reported.  
Outcome C. Rates of tobacco cessation of COPD patients was an outcome measure of the 
project.  Monthly queries were generated to determine the number of COPD patients whose 
tobacco use status was non-user.  Rates of tobacco cessation counseling and tobacco cessation 
are important to the treatment of COPD; tobacco use is the most important modifiable lifestyle 
factor (GOLD, 2019).   
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Outcome D. Rates of CAT symptom questionnaire use documented in the EHR were an 
outcome measure of the project. Monthly queries determined the number of COPD patients who 
complete the CAT symptom questionnaire.  Assessing symptoms with a standardized tool is an 
important component of GOLD strategy (GOLD, 2019).   Assessing the use of the questionnaire 
indicated uptake of the revised spirometry visit workflow.   
Outcome E. Rates of inhaled corticosteroid use were an outcome measure of the project.  
Monthly queries determined the number of COPD patients who had an active ICS or ICS 
combination prescription.  The most recent GOLD strategy recommends reserving inhaled 
corticosteroids for more advanced stages of the disease, exacerbations, and asthma/COPD 
overlap. 
Outcome F. Healthcare utilization of COPD patients was an outcome measure of the 
project evaluated by a review of patient charts. Charts were reviewed by the project lead to track 
the percentages of COPD patients with ED/hospital visits during the months of September, 
October, and November.  A retrospective chart audit on COPD patient’s visits during the same 
period in 2018 period was conducted for the comparison.  Data collected from the chart reviews 
were entered into an Excel spreadsheet identifying the number of ED visits/hospitalizations and 
primary symptoms reported (Appendix K).  Capturing healthcare utilization data was important 
to the project site and offered insight into managing exacerbations in the COPD patient 
population, congruent with GOLD strategy and Healthy People 2020.  Respiratory Diseases 
objectives RD-11 and RD-12 of HealthyPeople2020 specifically identify reductions in 
hospitalizations and ED visits related to COPD as target goals.     
Evaluation tool. Data collected from generated reports and chart reviews were entered 
into an Excel spreadsheet for data analysis.  Two tools were used for data collections: GOLD 
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Strategies Component tool (Appendix J) and Healthcare Utilization tool (Appendix K).  
Outcomes were reported as descriptive statistics, using percentages, and data was later displayed 
in tables and graphs.   
Data analysis. Data were analyzed according to improvements in rates of outcome 
measures A-F as described above, which are integral to the clinical application of GOLD 
strategy.  While GOLD strategy offers recommendations to improve the diagnosis, treatment, 
and management of COPD, no formal benchmarks have been established.  The clinic goal was 
70% spirometry for COPD patients and 100% tobacco cessation counseling.  The National 
COPD action plan and Healthy People 2020 have no benchmarks for outcome measures.    
 Data management.  Data was collected through the clinic EHR using system-generated 
reports and individual chart audits, then transferred to an Excel spreadsheet (Appendix J; 
Appendix K).  No patient identifiers were used when creating system generated reports; the 
fields were limited to currently active patients and patients with a COPD diagnosis.  Data were 
analyzed by the rates of specific outcomes.  Clinic generated medical record numbers were 
captured by the report query and used to identify redundancies during chart audits.   
The site champion and site director had access to the data, and storage methods were in 
compliance with clinic and university protocol.  Allscripts generated reports were available 
through the Allscripts software and backed up with the Allscripts server.  Data entered into Excel 
was stored on a password-protected computer in a locked office at the clinic. Any paper 
documents collected for chart audits stayed onsite at the clinic and were shredded after use.  
Summary 
 This chapter has outlined the overall creation and development of the project.  As part of 
the pre-implementation process, the project was deemed as quality improvement, not requiring 
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further IRB review. The relationship with the project site was mutually beneficial and supportive 
in planning and development.  Risk analysis offered insight into aspects of the project needing 
consideration, especially the resource limitations at the project site.  Data outcomes related to 
GOLD strategy for COPD patients were considered from initial idea through pre-implementation 
planning.  Data collection and analysis included tracking and trending the rates of specific 
patient outcomes in COPD management to evaluate uptake of the improvements in clinic 
workflow.  Descriptive statistics were used to describe outcome data, displayed with tables, 
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   Chapter Five:  Implementation Process 
This chapter will describe the setting, participants, and implementation process.  The 
implementation period was August through December 2019, with weekly onsite visits by the 
project lead.  Participants were staff and volunteers at the clinic, caring for COPD patients.  The 
project lead performed weekly spirometry testing and PDSA cycles to evaluate the revised 
workflow developed for spirometry testing.  Meanwhile, during the implementation period, the 
project lead tracked data from reports developed from the site electronic health record (EHR).  
The data outcome measures were derived from key points of GOLD strategy.   
Setting  
 The project took place at a community-based primary care clinic in rural southeastern 
NC.  The clinic is a 501(c)3 non-profit organization, unaffiliated with any organization or 
institution.  Funding is provided by grants, individual and corporate donations, church and civic 
group donations, and fundraisers.  The clinic serves qualifying low-income, uninsured adults 
currently residing in the county.  Overall the clinic serves approximately 1200 people a year.  At 
the start of the project, there were 113 active patients with a diagnosis of COPD.  Many other 
patients were awaiting spirometry testing to evaluate COPD as a suspected diagnosis.  The clinic 
interest in the project was improved patient care for COPD patients, as well as improved funding 
for grant and private donations.  Aspects of the project were congruent with patient-centered 
medical home measures.  Improvements in care and outcomes for COPD patients were also in 
line with the values and mission of the clinic.   
Participants 
Participants included the nursing staff and providers at the clinic who interact with COPD 
patients.  Inclusion criteria included any nurse or provider, paid or volunteer, working in the 
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clinic at the time of the project.  Nurses included one full-time employee, two volunteers 
currently providing support for spirometry visits, and another volunteer who collaborated with 
the project lead to make EHR modifications for the project. Providers include one full-time 
employee and up to four volunteer providers who saw patients during implementation.  The full-
time provider, also the project champion, was the primary provider for the purpose of the project.  
The primary provider was notified of completed spirometry visit results during the 
implementation period as part of the new workflow strategy. The primary provider then viewed 
results and signed off on encounters, making any changes to treatment plans and follow up.     
Recruitment 
Participants were a convenience sample due to their employment or volunteering 
schedules at the clinic during project implementation.  Onboarding of staff and providers 
occurred during a clinical staff meeting held on August 29 in which the project lead presented an 
educational module about the current GOLD strategy for care of COPD patients, an overview of 
the DNP project, and modifications to documentation in the EHR. Regular informal 
communication about the project occurred during weekly visits by the project lead.  Site 
champion and site director assisted in engaging staff and providers informally during daily 
operations at the clinic during project implementation. 
Informal conversations about the project with staff and volunteers prior to 
implementation were brief but encouraging.  Perceived barriers prior to implementation included 
time and resource limitations.  Employed staff is few, and each has a large scope of 
responsibilities and obligations related to the free clinic’s operations.  
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Implementation Process 
 The implementation process occurred during the Fall semester of 2019, from late August 
through December.  The project lead was present at the clinic weekly for spirometry visits, staff 
follow-up, and data gathering during the implementation period.   
EHR revisions.  Prior to the implementation period, automated monthly reports were 
created in the EHR by the project lead and site director.  These reports provided the data 
outcomes described in Chapter Four, demonstrating the effects of the project on COPD patient 
care.  The project lead examined these reports each month to track and trend outcomes data of 
the project (Appendix J; Appendix K). 
The project lead and site director made several modifications to the EHR to improve visit 
workflow.  First, a shortcut to commonly used orders was created for providers to access within 
the “COPD” diagnosis portion of the “Assessment & Plan.”  Second, the CAT questionnaire was 
flagged as a lab result within the EHR so that staff and providers could enter and track this data 
over time (Appendix B).  Third, changes were made to the “results” portion of the “in-house 
spirometry procedure” for more accurate documentation during spirometry visits.     
        Education modules and materials.  At the start of implementation, the project lead  
presented education during a regularly scheduled clinical staff meeting on August 29th.  The lead 
shared a brief synopsis of the project and information about GOLD strategy for COPD.  
Providers were instructed on changes to EHR workflow applicable to care of COPD patients at 
the clinic.  Special attention was given on the use of the COPD Assessment Test (CAT) for 
symptom assessment and the COPD Pocket Consultant to guide treatment (Appendix B; 
Appendix C).  All materials, including the PowerPoint presentation, were made available in a 
binder placed in the volunteer provider office.  The CAT questionnaire and COPD Pocket 
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Consultant were made available on the quick reference wall in the exam room hallway.  Nursing 
staff education occurred one-on-one with the project lead each week as the spirometry visit 
workflow was developed.  Two step-by-step workflow documents were created for spirometry 
visit performance and spirometry documentation (Appendix L; Appendix M).  These documents 
were made available in hard copy form with the equipment and electronically.  
Project lead visits.  Prior to implementation, the project lead volunteered at the site and 
conducted spirometry testing.  The project lead was on-site each Wednesday to perform 
spirometry visits during implementation to improve staff buy-in of the project and revise and 
evaluate the workflow in practice.  During implementation, the project lead facilitated teaching, 
assisting, and observing staff perform the revised spirometry workflow using the PDSA 
framework at regular intervals.  
The project lead gathered and evaluated data monthly on outcomes A-F: spirometry 
results, tobacco use status, tobacco cessation counseling, CAT symptom questionnaire, and 
inhaled corticosteroid prescriptions.  Each of the outcomes measured an aspect of GOLD 
strategy for primary care and was trended to evaluate for the uptake of the project.  Data were 
collected and entered in Excel spreadsheets (Appendix J).   
The charts of active COPD patients were evaluated for ED use and hospitalizations 
related to COPD during the same three-month period (September, October, and November) in 
2018 and 2019, outcome G.  Data was collected and entered in an excel spreadsheet on an 
ongoing basis throughout the implementation period (Appendix K).   
 PDSA cycles.  PDSA cycles of the spirometry visit, formal and informally, occurred 
during the project implementation.  The first three PDSA cycles involved an informal self-
assessment of the visit workflow by the project lead.  Informal PDSA cycles were focused on 
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streamlining the workflow for timeliness, capturing relevant data patient history information, and 
optimizing documentation.  Formal PDSA cycles evaluated monthly data outcome trends and 
observation of nurses conducting spirometry visits.  During the final PSDA cycle, nurses 
performed spirometry visits independently with revised workflow instructions and provided final 
feedback to the project lead.  The final version of the workflow was made available with 
spirometry equipment and on the clinic server (Appendix L; Appendix M).  
Plan Variation 
 Aspects of the project plan were revised during implementation, without deviating from 
the overall purpose of the project or requiring any change in data collection.  The opportunity for 
both onboarding and educating multiple providers and staff during the clinical meeting occurred 
at the start of implementation, eliminating the need for a separate information session.  As the 
project began, availability of staff and volunteers to observe and conduct spirometry visits was 
more limited than expected; as a result, one-on-one teaching of the revised spirometry visit and 
formal PDSA cycles were reduced in number.  Timeline for teaching and PDSA cycles was 
delayed by a change in equipment.  During the project, current equipment required parts that 
were no longer being manufactured related to age and the accuracy of the machine was 
questioned.  The site champion and site director agreed that new equipment was needed, and a 
spirometer was secured with minimal interruption to the project or scheduled spirometry visits. 
The project lead was responsible for learning and teaching the new equipment to staff and 
volunteers, which resulted in the delayed engagement of nurses.  
Summary 
This chapter has described the specific details of project implementation.  Participants 
and setting have been defined.  Strategies for communicating information about the project to 
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site participants and recruitment details have been discussed.   The implementation strategy for 
the project lead has been detailed: pre-implementation EHR adaptations and education materials, 
the performance of spirometry and PDSA cycles with staff, and data collection during 
implementation.  Variations in the plan have been described, adding context to the project 
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Chapter Six:  Evaluation of the Practice Change Initiative 
This chapter will describe the final data outcomes of the implementation project.  Short, 
intermediate, and long-term outcomes will be identified.  Findings will be characterized and 
visually displayed to demonstrate their relevance to practice change at the site.  The significance 
of each of the data outcome findings will be discussed, demonstrating relevance to GOLD 
strategy.  Successful uptake of the project and a trajectory towards sustainable change after 
implementation will be described.  
Participant Demographics 
 Project participants were staff and providers at the clinic.  During the project 
implementation period, there were six providers present at the site who were made aware of the 
changes to spirometry visit workflow, use of the CAT questionnaire, and the COPD pocket 
consultant. During the project implementation period, there were three staff and volunteers who 
directly performed the in-house spirometry visits with patients. Participants’ identities were kept 
confidential, and no other demographic data was obtained.   
  Aspects of care for COPD patients defined the outcome measures.  A COPD diagnosis in 
the site’s EHR and active patient status (defined as at least one visit in the 2019 calendar year) 
were the only demographic criteria included.  There was a total of 109 patients with the 
diagnosis of COPD at the beginning of the project compared to 126 patients at the end of the 
project.  The increase in numbers reflects both newly diagnosed patients with COPD as well as 
new patients entering the practice with the diagnosis of COPD.  No other demographic variables 
were collected for project outcome measures.    
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Intended Outcomes  
The primary project outcome was successful uptake of the revised spirometry visit 
workflow. This was demonstrated through the following short, intermediate, and long-term 
outcomes. 
The short-term outcome of the project was educating providers and staff on relevant 
components of GOLD strategy for primary care.  This outcome was met through the education 
session offered at the start of implementation, as described in Chapter Five.  An additional short-
term outcome was the creation and revision of a workflow for in-house spirometry based on 
existing process at the site (Appendix L; Appendix M).  Several informal PDSA cycles aided in 
the design of a final process to be adopted.  
Intermediate outcomes were identified as provider application of GOLD strategy and use 
of the revised spirometry visit workflow.  These outcomes were evaluated by systematically 
measuring components of GOLD strategy relevant to patient care at the project site.  As 
described in Chapter Five, rates of spirometry, tobacco cessation counseling, tobacco cessation, 
use of the CAT questionnaire, and inhaled corticosteroid (ICS) prescriptions rates were measured 
at the beginning and monthly during implementation. These outcomes demonstrated the impact 
of the education session and spirometry visit workflow.  Improvements in these areas, displayed 
in Table 1, show the influence of the project on patient care.   
The long-term outcome of the project is the continued use of the spirometry visit 
workflow and application of GOLD strategy after project completion.  Long term outcomes can 
be evaluated by the project site in the future using the queries developed during implementation.  
Long term outcomes were not assessed during implementation, given the short duration of the 
project period.   
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 Findings.  Project-specific findings, derived from data collected during the project, 
showed positive impacts on patient care at the site. These included increased rates of spirometry, 
increased tobacco cessation counseling, increased tobacco cessation, use of the CAT 
questionnaire, and a decrease in prescriptions for inhaled corticosteroids. Table 1 shows the 
measurable changes in practice through implementation. This table displays data outcomes for 
each measure of the project.  Rates, described as percentages, are shown for each month of data 
collection.  Trends for these measures demonstrate practice changes congruent with GOLD 
strategy.  They also reveal the successful uptake of education and workflow created for the site. 
Table 1 
Percentage Rates of COPD Patients Related to GOLD strategy Components 
 September October November December January 
Spirometry 63.7 67.3 70.7 70.5 71.4 
Tobacco Users 85.3 85 85.3 86 83.3 
Cessation Counseling 97.2 97.3 97.4 97.1 99 
ICS prescriptions 73.4 72.6 71.6 72.1 65 
CAT questionnaire  0 10.6 15.5 17 20.6 
           
           
           
 Initial rates of spirometry at the project site were 63.7% with gradual improvements to 
71.4% in the four-month implementation period.  This reflects an overall increase of 7.7% during 
implementation.  While there are no national standards, GOLD strategy recommends that all 
patients with COPD have the diagnosis confirmed with spirometry (GOLD, 2019).  The project 
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provided an overall increase in spirometry rates at the site, underscoring the importance of a 
spirometry confirmed diagnosis.  
 Rates of tobacco cessation counseling, which were near 100% before implementation, 
rising from 97.2% initially to 99% after project implementation. The standard of care specified 
by GOLD strategy is that all tobacco users with COPD be counseled to quit.  There are a variety 
of methods to explore based on provider and patient preference, availability, and the topic should 
be addressed as every encounter (GOLD, 2019). Tobacco cessation counseling was incorporated 
directly into the spirometry visit workflow (Appendix L; Appendix M). As the most important 
modifiable risk factor, tobacco cessation at the primary care level is crucial to the management of 
COPD.  
 Rates of tobacco use by patients with COPD showed a slight decrease during project 
implementation.  While chart audits revealed that no patients successfully quit during the project 
implementation, it was noted that some COPD patients were already non-users when they 
entered care at the site during the implementation period.  The small but 2% decrease in COPD 
patients using tobacco remains significant, demonstrating that clinician contact and counseling 
may play a role in aiding patients to quit. 
 Rates of CAT questionnaire usage increased from a baseline of zero, as this was a new 
practice change.  The CAT questionnaire was previously unknown to many of the project 
participants.  During monthly chart audits, it was seen that providers used the CAT questionnaire 
during routine patient encounters, an unanticipated but positive finding beyond the project intent.  
This combined use demonstrated a robust uptake of the questionnaire into clinical practice.  
Overall, CAT questionnaire usage went from 0 to 20.6% of patients with COPD over the four-
month implementation period.  As has been previously described, this a significant factor in the 
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treatment and pharmacological management of patients with COPD (GOLD, 2019).  The 
implications of CAT use overall are the improved assessment and treatment of COPD patients, 
as recommended by GOLD strategy.   
 Initial rates of ICS prescriptions were 73.4% prior to implementation, decreasing to 65% 
by end of the four-month project.  This slight decrease reflects an improvement consistent with 
GOLD strategy recommendation.  This was potentially reinforced by the availability of the 
COPD pocket consultant in the clinic after the education sessions.  GOLD strategy recommends 
the use of ICS for more advanced stages of COPD or refractory symptoms and exacerbations 
(GOLD, 2019).  Rates declined by 8% overall during project implementation.   
 Healthcare utilization was determined to be unchanged between the same four-month 
period in 2018 and 2019.  There was a total of 3 ED visits/hospitalizations related to COPD in 
the year 2018 compared the same number of ED visits/hospitalizations related to COPD seen in 
2019.  No further review was conducted related to this outcome and is not reflected in Table 1.  
Summary 
Findings from data collected during the project implementation period have been 
described and displayed in this chapter.  Measurable data outcomes reveal successful practice 
change and improved patient care of COPD patients congruent with GOLD strategy.  The 
primary outcome of the project was met, as well as the short-term and intermediate goals.  The 
workflow was successfully adapted into practice, and GOLD strategy was applied in patient care 
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Chapter Seven: Implications for Nursing Practice 
The American Association of Colleges of Nursing defined eight essentials in 2006 for  
doctoral nursing education and practice.  The DNP project, in general, fulfills these essentials in 
various ways throughout the process of development, implementation, synthesis, and 
dissemination.  This chapter will describe how each of the essentials was integrated into this 
project.  Implications for practice and specific examples related to each essential will be 
discussed. 
Practice Implications 
             Essential I: Scientific underpinnings for practice.  This essential engages nurses at the 
highest level of science, combining physical science with theory to evaluate and implement 
evidenced-based practice (AACN, 2006).  As applied to the project, this essential was 
demonstrated by the integration of clinical knowledge and practice.  Examples of this essential in 
the project included both the education component and PDSA workflow improvements.  
Understanding the pathophysiology and pharmacology of COPD provided the basis for applying 
diagnosis, treatment, and management recommendations as outlined in GOLD strategy.  This 
knowledge was then synthesized and presented to a variety of clinical roles.  The project lead 
also used the  PDSA model as the theoretical basis for practical application of the quality 
improvement project. Spirometry visit workflow was improved systematically using the PDSA 
model.  Implications to practice include the practical use of the PDSA model to improve an 
existing workflow.  Other implications for future practice include the ability to synthesize and 
present relevant information to primary care clinicians.   
 Essential II: Organization and systems leadership for quality improvement and 
systems thinking. This essential prepares the doctoral nurse to understand, engage, and promote 
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best practice at the highest level of a healthcare organization and patient care delivery (AACN, 
2006).  As applied to the project, this essential was demonstrated in the development of the 
project to address the specific needs of the project site.  Special care was taken to develop a 
quality improvement project that would limit the burden on staff and resources while also 
improving outcomes for patients.  Implications for practice include lessons learned about 
adapting a quality improvement project to a free clinic with minimal staff and resources.  An 
example of this essential included building data collection tools upon existing measures at the 
project site for a specific population, COPD patients.  Another example was the project lead’s 
ability, as an existing volunteer at the project site, to perform spirometry for patients during the 
project period, which  in turn provided ample opportunity to evaluate and adjust workflow and 
support staff at the site.     
             Essential III: Clinical scholarship and analytical methods for EBP.  This essential 
prepares the doctorate nurse to critically evaluate and translate clinical knowledge into practice 
(AACN, 2006).   Related to the project, the rigorous review of current literature informed the 
project design for best practice in COPD diagnosis, treatment, and management.  Implications 
for practice include the ability to create and utilize a literature matrix, synthesize information, 
and present topics to an interdisciplinary audience.  Examples of this essential included 
developing a thorough working knowledge of best practice specified in GOLD strategy, 
developing education and project components, and providing a short education module to 
interdisciplinary staff.   The project lead was able to critically evaluate guidelines, standards of 
care, and clinical tools for practice (such as the COPD pocket consultant used for the project) to 
develop and implement the project.  Implementation of the project utilized the PDSA model 
framework to design, perform, evaluate, and adapt the workflow for spirometry visits.  These 
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methods have implications for future nursing practice, providing practical application of the 
PDSA rapid cycle framework to improve an existing process.  
             Essential IV: Information systems/technology and patient care technology for the 
improvement and transformation of healthcare. This essential prepares the doctoral nurse to 
utilize and adapt rapidly changing healthcare technologies to best benefit patient care (AACN, 
2006).  As related to the project, this essential is defined as learning and adapting the project 
site’s electronic health record (EHR) to meet the design of the project.  Implications to nursing 
practice included improved informatics literacy and maintaining a multidisciplinary perspective 
on informatics systems.  For example, the project included strategic adjustments of EHR 
workflow for efficiencies in clinicians' time, thereby creating more meaningful encounters with 
patients.  Specific changes made to the EHR included: spirometry visit templates, order sets for 
providers, inhaler medication lists, and report queries for project data collection.   
             Essential V: Healthcare policy for advocacy in healthcare.  This essential prepares 
the doctoral nurse to critically analyze policy and demonstrate leadership in the public health 
sphere (AACN, 2006).  As applied to the project, this essential was demonstrated by the project’s 
alignment with COPD National Action Plan Goal 5: “Translate national policy, educational, and 
program recommendations into research and public health care actions” (NIH, 2017).  
Information technology in healthcare, through the EHR and data collection, is an important way 
in which practice standards become action.  Implications for future nursing practice include the 
experience of adopting an EHR to meet best practice standards.  Another implication to practice 
includes the successful implementation of a quality improvement project which translated 
measurable patient-related data outcomes.  This essential was demonstrated by clinical 
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application of the COPD Assessment Test (CAT) symptom questionnaire into patient visits as a 
lab value.  In this way, a standardized assessment tool was operationalized into practice.   
             Essential VI: Interprofessional collaboration for improving patient and population 
health outcomes. This essential prepares the doctoral nurse to understand and communicate with 
other healthcare disciplines as a leader in the team-based approach to healthcare (AACN, 2006).  
As applied to the project, this essential was demonstrated in communication between disciplines 
throughout all phases of the project.  The primary collaboration was between project lead, site 
director, staff NP, and staff nurses.  Implications for practice include timely, constructive 
communication, feedback, and collaboration about project goals.  Examples from the project 
include the following: leading the interprofessional team, reviewing and revising education 
components with project champion, modifying the EHR in collaboration with the site director, 
relationship building with the common goal of improving COPD patient care, and the 
unexpected task of teaching new spirometry equipment to staff during implementation.  Another 
important example of interprofessional collaboration included the revised spirometry visit 
structure, which standardized communication among care team members.  The use of the COPD 
pocket consultant was another example of a standardized communication tool among providers 
at the site. 
             Essential VII: Clinical prevention and population health for improving the nation’s 
health.  This essential focuses on the doctoral nurse as an advocate for population-level 
healthcare change to promote health and wellness through the lifespan (AACN, 2006).  As 
applied to the project, this essential was demonstrated in the project’s alignment with COPD 
National Action Plan Goal 2: “Improve the diagnosis, prevention, treatment, and management of 
COPD by improving the quality of care delivered across the health care continuum” (NIH, 
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2017).  Implications to practice include increased awareness of COPD management and the 
translation of COPD National Action Plan goals into future practice.  Specific examples of this 
essential include the dissemination of COPD best practices into the local community: volunteer 
providers and staff at the clinic will bring the principles learned about GOLD strategy through 
the project into various other practices throughout the community in which they work.  Examples 
of improvement in population health included improved rates of spirometry for diagnosing 
COPD, increased tobacco cessation counseling, decreased rates of tobacco use, and decreased 
rates of inhaled corticosteroid use.  
             Essential VIII: Advanced nursing practice.  This essential prepares the doctoral nurse 
to fully integrate their education and training into clinical practice (Moran, Burson, & Conrad, 
2017).  Implications of future practice include full understanding of the advanced practice nurse 
role in improving the health of populations.  In the project, this was demonstrated by 
relationship-building with site staff including the having a practicing nurse practitioner as  
project champion.  The project lead’s future practice and quality improvement initiatives are now 
informed by collaborating with a knowledgeable and experienced nurse practitioner clinician.  
The project lead, having successfully designed, implemented, and evaluated a quality 
improvement project, has demonstrated practicing to the full extent of education and training in 
the primary care setting.   
Summary  
        This chapter has included the eight essentials of DNP education and the relevance of each 
essential to the DNP project.  During phases of development, implementation, and evaluation, 
the project lead was able to utilize scientific process and current technology, translate knowledge 
into practice, design practice changes through multidisciplinary collaboration, with the ultimate 
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goal of improving COPD patient outcomes at the project site.  The DNP essentials have been 
demonstrated with specific examples, and implications for further nursing practice have been 
explored. In summary, the DNP project has provided extensive educational and experiential 
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Chapter Eight: Final Conclusions 
This chapter will describe the conclusions of the project and the importance of data 
outcome findings. A description of how COPD care at the project site improved during the four-
month implementation period will be provided. Project’s strengths and weaknesses and 
implications to practice will be discussed.  
Significance of Findings 
           The project outcomes demonstrate that standard care measures can positively influence 
patient outcomes for COPD patients at a primary care site. By creating awareness of GOLD 
strategy and implementing a standard procedure for spirometry visits, COPD management 
showed measurable improvement. 
           Project outcomes, described in Chapter Six, were developed from GOLD strategy and 
National COPD Action Plan goals.  The project outcomes showed an improvement in several 
components of best practice.  Key findings associated with improvement in care for patients with 
COPD included: increased rates of spirometry, increased counseling for tobacco cessation, and 
symptom assessment through use of the CAT questionnaire. The outcomes demonstrated 
efficiency of care and evidenced-based treatment at work in clinical practice. Such strategies can 
potentially decrease the likelihood of exacerbation rates and hospitalizations.   Triple Aim 
Initiatives, to improve the quality of care, the health of populations, and cost, were also advanced 
for COPD patients with the work of this project.  
           The project positively impacted the staff and providers at the site. The site welcomed the 
project, new information about COPD management was shared, and rural health grant funding 
was bolstered by the data generated in the project. Additionally, staff and volunteers performing 
spirometry visits remarked positively on several components of the project. Staff and volunteers 
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appreciated the revised visit structure, remarking on its’ ability to accomplish multiple tasks in a 
single patient encounter.  
Volunteer and staff providers were eager to use the COPD pocket consultant, a useful 
strategy for the dissemination of information. As many providers and staff work in settings 
beyond the project site, there was great potential for expanding GOLD strategy into community 
practice, reaching a higher population of patients with COPD. 
Project Strengths and Weaknesses 
         The strengths of the project included functionality and adaptability. Convenient hardcopy 
evidence-based materials were provided to the clinic, including the PowerPoint education 
module, COPD pocket consultant, and spirometry visit workflow. Data outcomes generated from  
the project were efficiently utilized to support grant funding opportunities for the year 2019. By 
the end of implementation, one staff and one volunteer were independently completing 
spirometry visits using the revised workflow. These various examples demonstrate that the 
project was adaptable, serving more than one purpose for the site.        
 Interprofessional collaboration was also identified as a key strength of the project.  By 
increasing awareness of GOLD strategy across several  disciplines in the clinic, there was a more 
unified approach to the care of COPD patients.  Interprofessional communication also improves 
the understanding of various roles at the site. 
Another strength of the project was improved education for patients with COPD. The 
revised spirometry workflow successfully included two essential points of education: tobacco 
cessation and inhaler use. Including time for both education pieces in the revised spirometry 
workflow, patients gained tools for disease self-management.  
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Provider education was another strength of the project. The introduction of the CAT 
questionnaire and COPD pocket consultant was an integral component to sustaining practice 
change. These tools standardized the large quantity of information contained in the 2019 GOLD 
strategy into a quick reference and were received with enthusiasm by the providers.   
An increase in the number of spirometry visits performed was another strength of the 
project. Weekly scheduled visits, compared to the usual standard of monthly, allowed for 
flexibility in scheduling for patients, opportunities for evaluation of the workflow with PDSA 
cycles, and input from the staff and volunteers. An increased number of visits also allowed for 
enough time in teaching the workflow to staff and volunteers.  
The weaknesses of the project included setbacks with equipment and change in EHR 
systems.  Spirometry equipment failures early in the implementation period were unexpected. It 
was the project lead’s responsibility to learn and teach the new equipment to staff, which delayed 
revising the spirometry visit workflow. This change delayed teaching the new process to staff 
and volunteers. Another unexpected event was a change of EHR systems at the end of 
implementation that led to a gap in documentation.  The revised workflow, which focused on 
EHR specific aspects of documentation, could not be directly applied to the new system. 
However, the essential points of the workflow can be adapted to the new system.   
Project Limitations 
          Project limitations were anticipated before implementation. Limitations of support staff, 
time, and budget were expected because of the site’s free and charitable status. Staffing was a 
limitation and consisted of one staff and one volunteer available to carry on the spirometry visits 
after completion.  
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Recruitment of additional volunteers, via email and in person, was initiated but 
unsuccessful. The frequency of visits was another limitation. While the project lead was able to 
conduct weekly spirometry visits during implementation, spirometry visits resumed a monthly 
frequency after that. The project time frame was a limitation with only four-month 
implementation period for collection of data on COPD care and management.  Healthcare 
utilization as a data outcome measure was also difficult to quantify because of the limited time 
frame of the project.  
Project Benefits 
          Patient care and efficiency were some of the most important overall benefits of the project. 
Improvements in the care of patients with COPD was crucial, in line with National COPD Action 
Plan goals, and demonstrated clearly in the data outcomes.  While the project did  not conduct a 
cost saving analysis, there were great potential cost savings associated with improved COPD 
care.   Reduced exacerbations and decreased hospital/ED use are directly in line with Triple Aim 
Initiatives and Healthy People 2020 goals.  Direct costs per patient with COPD, defined as 
medications and diagnostics, ED visits, and hospitalizations, as well as outpatient consultations, 
were recently estimated at $10,367 annually in the US (ur Rehman et al., 2019). Costs are 
directly influenced by disease severity and exacerbation frequency; therefore, the importance of 
early and frequent intervention at the primary care level cannot be underestimated (ur Rehman et 
al., 2019). This project has demonstrated ways in which best practice in an outpatient setting 
improve the downstream effects of COPD.  
The efficiency of care was another significant benefit of the project. The spirometry visit 
was designed to meet several goals and education points during one single encounter with COPD 
patients. Many patients at the site struggle with reliable transportation; therefore, maximizing 
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visit efficiency is vital. Having a standardized procedure, repeatable for each spirometry visit, 
greatly benefits the project site (Appendix L; Appendix M). Other benefits included the zero cost 
of the project. Minimal disruption to the overall workflow of the clinic was another benefit. 
Spirometry visits were conducted in a similar manner and time frame.   
 Practice Recommendations 
          It is recommended that the practice continues with the revised spirometry workflow. The 
site should strongly consider adapting the revised workflow into the new EHR system. The 
workflow can be altered for documentation purposes, focusing on the implementation of the 
CAT questionnaire, tobacco cessation counseling, and inhaler education into the workflow. A 
potential improvement could be the evaluation of the new spirometry equipment functionality 
and direct linkage with the new EHR. This type of connectivity would limit the steps required in 
workflow and documentation.  
           It is also recommended that the site continue to utilize the COPD pocket consultant in 
practice. Fifty copies of the pocket guide were given to the clinic for future use, and information 
was provided about obtaining more at a minimal cost. This pocket guide contains the CAT 
questionnaire, treatment, and medication recommendations, tobacco cessation and vaccination 
guides, and more. COPD pocket consultant is also available in the form of a free web-based 
smartphone app. These are essential clinical decision-making tools for the care and management 
of COPD patients, which can become an essential force for practice change beyond the project 
site. 
It is recommended that GOLD strategy awareness continue to increase beyond the scope 
of this project.  Keeping advised of treatment updates using continuing education on GOLD 
strategy is a key component of continuing advanced provider practice.  As the education was 
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available to providers who work in wider community settings, this project reached more staff and 
patients than was originally intended.  Greater community awareness of GOLD further advanced 
the ultimate aims of the COPD National Action, Healthy People 2020 goals, and Triple Aim 
Initiatives. 
Final Summary 
          To conclude, the implementation project successfully improved COPD patient care at the 
project site.  The clinical implications of the project, seen in the data outcomes, demonstrate that 
the project successfully improved the care of patients with COPD in an outpatient setting. Staff 
and providers were engaged in the education, workflow changes, and outcome measures, and 
plan to adopt the workflow into clinical practice.  Education and a revised workflow improved 
COPD patient care at the site.  COPD National Action Plan goals were advanced by this project, 
providing community and clinic awareness of GOLD strategy and improving COPD patient care 
outcomes. Ultimately, this project served the Triple Aim Initiatives: to improve the quality of 
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Appendix A 
Refined ABCD Assessment Tool 
 
 The refined ABCD assessment tool.  FEV1: forced expiratory volume; FVC: forced vital 
capacity; mMRC: modified Medical Research Council; CAT: COPD Assessment Test. Adapted 
from Global Initiative for Chronic Obstructive Lung Disease (GOLD), (2019). Global strategy 
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Appendix B 
CAT Symptom Questionnaire 
 
 COPD assessment test (CAT), for use with refined ABCD assessment tool.  Adapted from 
“Development and first validation of the COPD Assessment Test” by P.W. Jones, G. Harding, P. 
Berry, I. Wiklund, W.H. Chen, & N.K. Leidy, 2009, European Respiratory Journal, 34(3), 648-
654.  Copyright 2009 by GlaxoSmithKline. 
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Appendix D 
Literature Search Flow Diagram 
724 published articles in the last 5 years  
using search terms GOLD, COPD,  
primary care, global strategy for the diagnosis,  
management and prevention of COPD. 
 
86 articles after excluding drug trials, oxygen 
supplementation, surgical interventions, pulmonary  
rehabilitation studies, co-morbidities, 
asthma and asthma/COPD overlap, and settings  
other than primary care. 
 
53 articles with relevant abstract  
information containing GOLD recommendation 
adherence, COPD care management,  
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Appendix E 
Literature Matrix 
Article Level of 
Evidence      





Use of Evidence 
in EBP Project 
Plan                        
          
Davis et al. 
(2015) 
VI International survey of 
physicians in 12 
countries, 1307 total. 
Primary care providers 
(PCP) use spirometry @ 
82%, Respiratory 
Specialists (RS) 100%; 
RS 93% likely to report 
awareness of GOLD 
strategy (vs PCP 58%). 




(1st/2nd choice) patterns 
in agreement with 
RSs are slightly 
better at the 
awareness of and 











strategies at the 
project site 
should be aimed 
at understanding 






medications.   
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GOLD for a category B 
patient was 38% versus 
67%. For GOLD C 
PCPs/RSs were 
concordant 40% vs 38%; 
w/ D type was nearly the 







Review examining the 
role of LABDs (long-
acting bronchodilators), 
administered as 
monotherapy or as part 
of dual or triple 
combination therapy, w/ 
focus on the effect on 
exacerbations.  Did not 
discuss methods AT 
ALL. 26 clinical trials 
and studies included.  
 Caution should 
be used with 




for patients with 
asthma overlap 















overuse of ICS. 
Algorithm for 
exacerbations. 
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Sehl et al. 
(2018) 
V A literature review 












varies widely.  
The largest gaps 







inhaler use, and 
referral to 
pulmonary 
rehab.  Barriers 
to adherence 
include lack of 
familiarity with 
guidelines and 
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Overington et 
al. (2014) 
V General overview review 
of GOLD adherence, no 
method listed, studies 
cited are measuring 
different aspects.  
Clinical practice 
compares to GOLD 
guidelines very poorly. 
One US study showed 
that only 56% of pt 
received treatment 
concordant w/ GOLD 
(meds). Another US 
study showed 3% of 
patients (chart reviews) 




comorbidities, and risk 
reduction strategies).  
Adherence to 
GOLD 
guidelines is not 
optimal and 
varies widely. 
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Riley & 
Sciurba (2019) 
I Expert opinion/clinical 
review/education module 
by JAMA about current 
standards/guidelines for 
"diagnosis and outpatient 
management of COPD): 
26 clinical trials, 21 
meta-analysis, 25 
observational studies, 18 
guidelines were 





however, a new 
algorithm (with 
same principles) 





on the category 
of GOLD (by 
spirometry) and 
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Karloh et al. 
(2016) 
I 17 studies were 
systematically reviewed 
to identify clinical 
outcomes and 
classification of GOLD 
stages of COPD.  
Different proportions of 
patients in each GOLD 
category were found 
using the MRC>2 and 
CAT>10,  with a 13% 
difference in distribution 
depending on the tool 
used.  









mortality.  It is 
not equivalent to 
the MRC using 





verified as a 
useful tool, but 





Only one tool 
should be 
implemented at 
the practice.  
Gupta et al. 
(2014) 
I A systematic review of 
the CAT assessment test 
examined 36 studies that 
were prospective cohorts 
or cross-sectional. 
Internal consistency was 
good, test-retest 
reliability was good.  





validity of the 
CAT.  







use for the 
proposed project. 
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had fair  methodological 
quality. MCID (a 
minimum clinically 
important difference) 
was inconsistent.  
Validity was examined 






n et al. (2015) 
IV Population-based 
epidemiological study of 
approximately 40,000 
people in Spain 
examining initial 
diagnosis of COPD, 
categorizations, use of 
bronchodilators and ICS, 
and exacerbation 
patterns.  Only 78% of 
COPD patients received 
treatment after diagnosis.  
17% of exacerbators 
were untreated; 13% of 
initial treatment 
patterns of 






are not treated 
with medications 







guidelines is not 
optimal; 
education for 
primary care will 
be relevant and 
useful 
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severe disease COPDers 
were untreated; 50% of 
all COPD patients were 
prescribed ICS alone or 
in combo at initial 
diagnosis. FLAW: 1/2 of 
patients diagnosed with 








IV 445 patients with COPD 
were reclassified into 
categories using the 
MRC and CAT.  MRC 
reclassified 47% of 
patients; CAT 
reclassified 41%.  MRC 
showed a relatively 
equal distribution of 
patients within the 
ABCD categories, while 
CAT distributed more 
patients into B & C 












than less.  
HOWEVER, the 
design of this 






critical to pick 
one tool, teach it, 
and remain 
consistent 
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spirometry, which is the 
undisputed best practice 
standard) 
study is flawed 
from the start r/t 






s for using 
symptom burden 
questionnaires.  
Jiang et al. 
(2015) 
II 1 yr. cluster-randomized 
field trial, 711 COPD 
patient in a primary care 
practice in China; 
comparing GOLD 
guideline intervention 
group to the usual care 
control group.  Found a 
significant difference 
between groups in 6-
minute walk distance 

















does improve life 
for COPD 
patients 
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(using MRC symptom 
burden questionnaire) 
Fathima et al. 
(2014) 
I A systematic review of 
19 Randomized control 
trials- most conducted w/ 





asthma and COPD care 
74% of the studies, with 
statistically significant 
improvement in the 
primary outcomes 
measured.  
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Parker et al. 
(2013) 
I PLANNED RCT for 
implementation of 
GOLD guidelines. Using 
evaluation/feedback/focu




activation tool (an 
interactive iPad with 
wireless 
data transfer to the 
spirometer); a web-based 
COPD guideline tool to 
be used by primary care 
providers as a 
decision support tool; 
and a COPD patient 
education toolkit to be 
used by the practice 
team."  Next phase (with 
results still unpublished) 
"RCT will be performed 
Results not yet 
published 
The results of 
this study would 
be key to 
implement 
strategies for the 
proposed project.  
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with one year of 
intervention within 30 
primary care practices."  
The effectiveness of 
materials will be 
evaluated, and clinically 
relevant outcomes will 
be compared to usual 
care.  
Foster et al. 
(2007)  
VI Survey of 784 primary 
care physicians 
regarding education 
needs for diagnosis, 
treatment, and 
management of COPD.  
55% were aware of 
GOLD, yet only 25% 




not yet reached 
primary care 
providers.  
Choices made by 







COPD.  Internet 
Can't find 
anything more 
recent w/ survey 
data of physician 
responses about 
how they are 
using 
recommendations





















guidelines are not 
representative of 
current practice, 
as the guidelines 
have been 
updated several 
times since.  The 
need expressed 
by physicians for 
more education 
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Bryant et al. 
(2013) 
I Systematic review of 
effectiveness of 
interventions designed to 
improve medication 
adherence in a COPD 
population.  5 studies 
were examined, with 
interventions including: 
brief counseling, 
monitoring and feedback 



























outcomes are not 
robust, and more 
research is 





I Literature review of 
GINA (asthma) and 
GOLD (COPD) 




there is a 
considerable 




usage would be 
worthwhile to 
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specific guidance.  
Limited information was 
found, with less than 2% 
demonstrating and 
testing correct inhalation 
technique: less than 3% 
of pages or references or 
tables/figures dedicated 
to devices. Results in 
ACCP/ACAAI device 
selection guideline were 
the best (54% of pages, 
88% of tables/figures 
and 82% of references), 










include in this 
project 




using insurance claims 
data, of nearly 20,000 
COPD patients (primary 
or secondary diagnosis) 
examining patterns of 
There was not a 
significant 
difference in 






the use of LABD 
for certain 
categories of 
COPD in this 
project 
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bronchodilator use in the 
time frame prior to and 
just after hospitalization 
for exascerbation.   40% 
patients filled a 
prescription for LABD 
in the 90 days prior to 
hospitalization; 56% 
patients filled a LABD 
prescription in the 90 








Simeone et al. 
(2017) 
IV A retrospective study 
using claims data in a 
four year period for the 
use of triple therapy 
(both LABD +ICS), as 
well as to characterize 
patients on triple therapy 
for concordance with 
GOLD guidelines (per 
stage of illness).  25% of 
all COPD patients 
received triple therapy.  
Triple therapy is 







help prevent the 
overuse of 
medications 
(such as ICS or 
triple therapy) 
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75% of those patients 
receiving triple therapy 
were of the lowest 
severity of illness, 
contrary to GOLD 
guidelines.  
Casanova et al. 
(2015) 
IV An observational cohort 
of 768 Spanish patients 
with COPD, comparing 
the predictive abilities of 
the CAT and MRC 
questionnaires.  Higher 
scores, regardless of 
questionnaire, were 
similar in sensitivity and 
corresponded to higher 
mortality.   
Again, problems 




to have MRC 









consistent use of 
one tool is going 
to be best 
practice 
Kruis et al. 
(2013) 
I Systematic review and 
meta-analysis of 26 trials 
involved approximately 
3000 patients in 11 
countries, in all types of 
healthcare settings 
IDM improved 





This data is 
important to the 
proposed project 
in terms of 
measurable data.  
Hospital 
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(primary, secondary, and 
tertiary care).  Integrated 
disease management 
interventions were 
examined, defined as at 











hospital days per 
person.  











IV A cross-sectional, 
retrospective study of 
1500+ medical records 
(11 primary care sites) to 
measure adherence to 
GOLD 
recommendations.  
Measured the following: 










in primary care is 
inconsistent.  
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spirometry values in the 
record, comorbid 
conditions treatment, 
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Appendix F 
Diffusion of Innovation Theory 
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Appendix H 
Project Expense Budget 
Line Item Unit Cost Unit Quantity Total 
Hospitality 
   
Food/Drink $30  1 $30  
Materials 
   
Lamination  $1 20 $20  
COPD pocket consultants (free)  
shipping cost required 
$17.50  1 $17.50 
Printing           0.10                   150                             $15.00
Total Expenses 
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Appendix J 



















September %  63.70% 85.30% 97.20% 73.40% 0% 
Sept # patients 109 72 93 90 80 0 
October %  67.30% 85% 97.30% 72.60% 10.60% 
Oct # patients 113 76 96 93 82 12 
November %  70.70% 85.30% 97.40% 71.60% 15.50% 
Nov # patients 116 82 99 97 83 18 
December %  70.50% 86% 97.10% 72.10% 17% 
Dec # patients  122 86 105 102 88 21 
January %  71.40% 83.30% 99% 65% 20.60% 
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Appendix K 
Evaluation Tool: Healthcare Utilization 
 
ED/hospitalizations 
related to COPD 
Raw data # of visits  2018 3 
% visits 8/28/2018-12/30/2018 2% 
Raw data # of visits 4 
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Appendix M 
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